Quidel (NASDAQ:QDEL) will release its earnings data after the market closes on Wednesday, February 21st. Analysts expect Quidel to post earnings of $0.20 per share for the quarter.
Shares of Quidel (QDEL) opened at $45.87 on Monday. Quidel has a 52 week low of $20.43 and a 52 week high of $49.47. The company has a quick ratio of 5.68, a current ratio of 6.28 and a debt-to-equity ratio of 0.70.
Several research firms recently commented on QDEL. BidaskClub lowered shares of Quidel from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Piper Jaffray Companies reissued a “buy” rating and set a $60.00 price objective on shares of Quidel in a research note on Wednesday, January 24th. Barclays boosted their price objective on shares of Quidel from $50.00 to $60.00 and gave the stock an “overweight” rating in a research note on Monday, January 22nd. CL King raised shares of Quidel from a “neutral” rating to a “buy” rating and set a $52.00 price objective on the stock in a research note on Thursday, January 4th. Finally, Zacks Investment Research lowered shares of Quidel from a “hold” rating to a “strong sell” rating in a research note on Thursday, December 28th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $53.50.
COPYRIGHT VIOLATION NOTICE: “Quidel (QDEL) to Release Quarterly Earnings on Wednesday” was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2018/02/19/quidel-qdel-to-release-quarterly-earnings-on-wednesday.html.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.